The Leprosy Mission

[2] Its beginning marked by from the time that Wellesley Bailey and his wife Alice began regular meetings in Dublin to tell friends about their experiences of people affected by leprosy in India, and to raise money'.

His friend Dr Morrison, a leader of the American Presbyterian Mission in Ambala, explained that they were suffering from leprosy.

Afterwards he wrote: "I almost shuddered, yet I was at the same time fascinated, and I felt that if there was ever a Christ-like work in the world it was to go amongst these poor sufferers and bring them the consolation of the gospel.

"[7] 1874-1893 – The Baileys travel extensively in India to see the need of people affected by leprosy and to encourage support work and donations.

1891 – Wellesley Bailey visits Mandalay, Burma, to open the first MTL home for leprosy-affected people outside India.

[9] 1940s – In South India, Paul Brand pioneers medical research and reconstructive surgery on leprosy deformities in hands and feet.

: 107 1980 – Vincent Barry and his team win the 1980 UNESCO Science Prize for their discovery of anti-leprosy drug clofazimine, developed with the assistance of The Leprosy Mission.

National Committees are in Australia, Belgium, Canada, Denmark, Eire, Finland, France, Germany, Italy, New Zealand, Northern Ireland, Scotland, South Africa, Spain.

These hospitals are centres of excellence that provide care to leprosy patients, as well as meeting the medical needs of the surrounding communities.

[11] There are mobile prosthetic units in Nigeria and Myanmar that provide medical care to those who have lost their limbs.

The Leprosy Mission supports a number of hospitals in Asia and Africa that are owned by the government or local church.

[citation needed] People affected by leprosy are often ostracised by their communities, which prevents them from being able to participate in the economic, social, and political life of the society in which they live.

This training ensures that people affected by leprosy know their rights and have the self-confidence to lobby for change at the local and national governmental levels.

TLM partners with governments and other leprosy NGOs to conduct active case findings, implement contact tracing alongside the distribution of a post-exposure prophylactic, and raise awareness within targeted communities.